Abstract:BACKGROUND:Copy number variations (CNVs) of chromosomal region 22q11.2 are associated with a subset of patients with congenital heart disease (CHD). Accurate and efficient detection of CNV is important for genetic analysis of CHD. The aim of the study was to introduce a novel approach named CNVplex®, a high-throughput analysis technique designed for efficient detection of chromosomal CNVs, and to explore the prevalence of sub-chromosomal imbalances in 22q11.2 loci in patients with CHD from a single institute.RESULTS:We developed a novel technique, CNVplex®, for high-throughput detection of sub-chromosomal copy number aberrations. Modified from the multiplex ligation-dependent probe amplification (MLPA) method, it introduced a lengthening ligation system and four universal primer sets, which simplified the synthesis of probes and significantly improved the flexibility of the experiment. We used 110 samples, which were extensively characterized with chromosomal microarray analysis and MLPA, to validate the performance of the newly developed method. Furthermore, CNVplex® was used to screen for sub-chromosomal imbalances in 22q11.2 loci in 818 CHD patients consecutively enrolled from Shanghai Children's Medical Center. In the methodology development phase, CNVplex® detected all copy number aberrations that were previously identified with both chromosomal microarray analysis and MLPA, demonstrating 100% sensitivity and specificity. In the validation phase, 22q11.2 deletion and 22q11.2 duplication were detected in 39 and 1 of 818 patients with CHD by CNVplex®, respectively. Our data demonstrated that the frequency of 22q11.2 deletion varied among sub-groups of CHD patients. Notably, 22q11.2 deletion was more commonly observed in cases with conotruncal defect (CTD) than in cases with non-CTD (P<0.001). With higher resolution and more probes against selected chromosomal loci, CNVplex® also identified several individuals with small CNVs and alterations in other chromosomes.CONCLUSIONS:CNVplex® is sensitive and specific in its detection of CNVs, and it is an alternative to MLPA for batch screening of pathogenetic CNVs in known genomic loci.

Evaluation of detection and analysis of chromosome 22ql 1.2 microdeletion by multiple ligation-dependent probe amplification assay

[Evaluation of Detection and Analysis of Chromosome 22q11.2 Microdeletion by Multiple Ligation-Dependent Probe Amplification Assay].

[Study on Clinical Features and Fluorescence in Situ Hybridization Detections of 22q11 Microdeletion Syndrome].

Chromosome Microdeletions Detected in Mental Retardation

Diagnosis of 22q11 Deletion and Duplication in Congenital Heart Disease by Multiplex Ligation-Dependent Probe Amplification

Prenatal Diagnosis of Microdeletions or Microduplications in the Proximal, Central, and Distal Regions of Chromosome 22q11.2: Ultrasound Findings and Pregnancy Outcome.

[Chromosome 22q11.2 Microdeletion and Phenotype Analysis of Patients with Non-Syndromic Tetralogy of Fallot].

Comparative Study of Three PCR-Based Copy Number Variant Approaches , CFMSA , M-PCR , and MLPA , in 22 Q 11 . 2 Deletion Syndrome

A Novel Multiplex Assay Wth 5 Strp Markers For Screening And Diagnosing 22q11.2 Deletion

[Clinical Detection of 22q11 Microdeletion in the Patients with Congenital Heart Disease by Multiplex Ligation Dependent Probe Amplification].

A Rapid Method for Molecular Diagnosis of 22q11.2 Microdeletion Syndrome

Rapid Detection of the 22q11 Micro- Deletion with Quantitative Real - Time Polymerase Chain Reaction

22Q11 Microdeletion Test in Patients with Congenital Heart Defects by Quantitative Fluorescent PCR

[Multiplex ligation-dependent probe amplification for detecting submicroscopic chromosomal abnormalities in Chinese children with global developmental delay or intellectual disability].

Clinical study of MLPA technology combined with chromosomes karyotype analysis in detecting child development disorders

A Novel Case of 15q24 Microdeletion Syndrome Detected by MLPA in a Chinese Family.

Applying Microarray to Detect 22 q11 . 2 Microdeletion Syndrome in Diagnosis and Prenatal Diagnosis

Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients.

A novel competitive fluorescent multiplex STR polymorphism assay for rapid, reliable and single-tube screening of 22q11.2 copy-number aberrations.

[Detection and related analysis to chromosome 22q11 microdeletion in patients with congenital heart diseases].

A Modified Multiplex Ligation-Dependent Probe Amplification Method for the Detection of 22q11.2 Copy Number Variations in Patients with Congenital Heart Disease.